Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature

  • Sofiane Maza
  • Uwe Trefzer
  • Maja Hofmann
  • Silke Schneider
  • Christiane Voit
  • Thomas Krössin
  • Andreas Zander
  • Heike Audring
  • Wolfram Sterry
  • Dieter L. Munz
Original article

Abstract

Purpose

Merkel cell carcinoma (MCC) is the most aggressive of the cutaneous malignancies, showing a propensity to spread to regional lymph nodes (LNs). The aim of this prospective study was to examine the feasibility and clinical impact of sentinel lymph node biopsy (SLNB) in this cutaneous malignancy.

Methods

The study population comprised 23 patients with stage I MCC (median age 70 years, range 50–85 years). Lymphoscintigraphic mapping with 99 mTc-nanocolloid was performed in all patients. Sentinel lymph nodes (SLNs) were identified, excised and analysed in serial sections by conventional histopathology and cytokeratin-20 immunohistochemistry.

Results

Metastatic disease was determined in the SLNs of 11 patients (47.8%). Elective lymph node dissection (ELND) was performed in eight of these 11 patients, four of whom had additional positive LNs. During follow-up (median 36.1 months, range 3–79 months), seven of the 23 patients (30%) relapsed: four had a local recurrence and three, in-transit metastases. Recurrence developed in two SLN-negative patients with local LN metastases and in one SLN-positive patient with distant metastases. This patient died, representing the only tumour-related death in our sample. Median survival was 49.1 and 35.5 months for SLN-negative and SLN-positive patients, respectively. This difference was not statistically significant (p=0.3452).

Conclusion

SLNB allows for exact nodal staging in patients with MCC. Whether additional ELND is of further benefit remains unclear.

Keywords

Sentinel lymph node biopsy Lymphoscintigraphy Merkel cell carcinoma 

References

  1. 1.
    Hitchcock CL, Bland KI, Laney RG 3rd, Franzini D, Harris B, Copeland EM 3rd. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg 1988;207:201–7PubMedCrossRefGoogle Scholar
  2. 2.
    Shaw JH, Rumball E. Merkel cell tumour: clinical behaviour and treatment. Br J Surg 1991;78:138–42PubMedCrossRefGoogle Scholar
  3. 3.
    Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:1514–9PubMedGoogle Scholar
  4. 4.
    Raaf JH, Urmacher C, Knapper WK, Shiu MH, Cheng EW. Trabecular (Merkel cell) carcinoma of the skin. Treatment of primary, recurrent, and metastatic disease. Cancer 1986;57:178–82PubMedCrossRefGoogle Scholar
  5. 5.
    Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8:153–8. Erratum in: Cancer Epidemiol Biomarkers Prev 1999 8:485PubMedGoogle Scholar
  6. 6.
    Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004;5:593–9PubMedCrossRefGoogle Scholar
  7. 7.
    Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002;20:588–98PubMedCrossRefGoogle Scholar
  8. 8.
    Victor NS, Morton B, Smith JW. Merkel cell cancer: is prophylactic lymph node dissection indicated? Am Surg 1996;62:879–82PubMedGoogle Scholar
  9. 9.
    Voog E, Biron P, Martin JP, Blay JY. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999;85:2589–95PubMedCrossRefGoogle Scholar
  10. 10.
    Kokoska ER, Kokoska MS, Collins BT, Stapleton DR, Wade TP. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997;174:688–93PubMedCrossRefGoogle Scholar
  11. 11.
    Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716–31PubMedCrossRefGoogle Scholar
  12. 12.
    Seregni E, Chiti A, Bombardieri E. Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results. Eur J Nucl Med 1998;25:639–58PubMedCrossRefGoogle Scholar
  13. 13.
    Kwekkeboom DJ, Krenning EP, de Jong M. Peptide receptor imaging and therapy. J Nucl Med 2000;41:1704–13PubMedGoogle Scholar
  14. 14.
    Oberg K. State of the art and future prospects in the management of neuroendocrine tumors. Q J Nucl Med 2000;44:3–12PubMedGoogle Scholar
  15. 15.
    Boerman OC, Oyen WJG, Corstens FHM. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals. Semin Nucl Med 2000;30:195–208PubMedCrossRefGoogle Scholar
  16. 16.
    Lampreave JL, Benard F, Alavi A, Jimenez-Hoy-uela J, Fraker D. PET evaluation of therapeutic limb perfusion in Merkel’s cell carcinoma. J Nucl Med 1998;39:2087–90PubMedGoogle Scholar
  17. 17.
    Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456–66PubMedCrossRefGoogle Scholar
  18. 18.
    Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–8PubMedCrossRefGoogle Scholar
  19. 19.
    O’Brien CJ, Uren RF, Thompson JF, Howman-Giles RB, Petersen-Schaefer K, Shaw HM, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461–6PubMedCrossRefGoogle Scholar
  20. 20.
    Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217–24PubMedCrossRefGoogle Scholar
  21. 21.
    Alex JC, Krag DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin North Am 1996;5:33–41Google Scholar
  22. 22.
    Messina JL, Reintgen DS, Cruse CW, Rappaport DP, Berman C, Fenske NA, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997;4:389–95PubMedCrossRefGoogle Scholar
  23. 23.
    Pfeifer T, Weinberg H, Brady MS. Lymphatic mapping for Merkel cell carcinoma. J Am Acad Dermatol 1997;37:650–1PubMedCrossRefGoogle Scholar
  24. 24.
    Ames SE, Krag DN, Brady MS. Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases. J Surg Oncol 1998;67:251–4PubMedCrossRefGoogle Scholar
  25. 25.
    Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288–92PubMedCrossRefGoogle Scholar
  26. 26.
    Hill AD, Brady MS, Coit DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 1999;86:518–21PubMedCrossRefGoogle Scholar
  27. 27.
    Koops HS, Doting MH, de Vries J, Tiebosch AT, Plukker JT, Hoekstra HJ, et al. Sentinel node biopsy as a surgical staging method for solid cancers. Radiother Oncol 1999;51:1–7PubMedCrossRefGoogle Scholar
  28. 28.
    Sian KU, Wagner JD, Sood R, Park HM, Havlik R, Coleman JJ. Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma. Ann Plast Surg 1999;42:679–82PubMedCrossRefGoogle Scholar
  29. 29.
    De Cicco C, Sideri M, Bartolomei M, Grana C, Cremonesi M, Fiorenza M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000; 82:295–9PubMedCrossRefGoogle Scholar
  30. 30.
    Zeitouni NC, Cheney RT, Delacure MD. Lymphoscintigraphy, sentinel lymph node biopsy, and Mohs micrographic surgery in the treatment of Merkel cell carcinoma. Dermatol Surg 2000;26:12–8PubMedCrossRefGoogle Scholar
  31. 31.
    Munz DL, Altmeyer P, Sessler MJ, Hor G. Axillary lymph node groups—the center in lymphatic drainage from the truncal skin in man. Clinical significance for management of malignant melanoma. Lymphology 1982; 15:143–7PubMedGoogle Scholar
  32. 32.
    Munz DL, Maza S, Ivancevic V, Geworski L. Classification of the lymphatic drainage status of a primary tumour: a proposal. Nuklearmedizin 2000; 39:88–91PubMedGoogle Scholar
  33. 33.
    Maza S, Valencia R, Geworski L, Zander A, Drager E, Winter H, et al. Temporary shielding of hot spots in the drainage areas of cutaneous melanoma improves accuracy of lymphoscintigraphic sentinel lymph node diagnostics. Eur J Nucl Med Mol Imaging 2002;29:1399–402PubMedCrossRefGoogle Scholar
  34. 34.
    Maza S, Valencia R, Geworski L, Sandrock D, Zander A, Audring H, et al. Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study. Eur J Nucl Med Mol Imaging 2003; 30:538–44PubMedCrossRefGoogle Scholar
  35. 35.
    Su LD, Lowe L, Bradford CR, Yahanda AI, Johnson TM, Sondak VK. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 2002;46:661–6PubMedCrossRefGoogle Scholar
  36. 36.
    Stadelmann WK, Cobbins L, Lentsch EJ. Incidence of nonlocalization of sentinel lymph nodes using preoperative lymphoscintigraphy in 74 consecutive head and neck melanoma and Merkel cell carcinoma patients. Ann Plast Surg 2004;52:546–9PubMedCrossRefGoogle Scholar
  37. 37.
    Schwarz M, Schwarz O, Audring H, Kuchler I, Winter H. Regional lymph node morphology in malignant melanomas and their prognostic value. Zentralbl Pathol 1994;139:457–64PubMedGoogle Scholar
  38. 38.
    Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1995;31:325–31PubMedCrossRefGoogle Scholar
  39. 39.
    Fenig E, Brenner B, Katz A, Rakovsky E, Hana MB, Sulkes A. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997;80:881–5PubMedCrossRefGoogle Scholar
  40. 40.
    Mehrany K, Otley CC, Weenig RH, Philips PK, Roenigk RK, Nguyen TH. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002;28:113–7PubMedCrossRefGoogle Scholar
  41. 41.
    Blom A, Kolb F, Lumbroso J, Duvillard P, Mamelle G, Morzli K, et al. Significance of sentinel lymph node biopsy in Merkel cell carcinoma. Analysis of 11 cases. Ann Dermatol Venereol 2003;130:417–22PubMedGoogle Scholar
  42. 42.
    Michl C, Starz H, Bachter D, Balda BR. Sentinel lymphonodectomy in nonmelanoma skin malignancies. Br J Dermatol 2003;149:763–9PubMedCrossRefGoogle Scholar
  43. 43.
    O’Connor WJ, Brodland DG. Merkel cell carcinoma. Dermatol Surg 1996;22:262–7PubMedCrossRefGoogle Scholar
  44. 44.
    Kurul S, Mudun A, Aksakal N, Aygen M. Lymphatic mapping for Merkel cell carcinoma. Plast Reconstr Surg 2000;105:680–3PubMedCrossRefGoogle Scholar
  45. 45.
    Wasserberg N, Schachter J, Fenig E, Feinmesser M, Gutman H. Applicability of the sentinel node technique to Merkel cell carcinoma. Dermatol Surg 2000;26:138–41PubMedCrossRefGoogle Scholar
  46. 46.
    Bilchik AJ, Giuliano A, Essner R, Bostick P, Kelemen P, Foshag LJ, et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am 1998;4:351–8PubMedGoogle Scholar
  47. 47.
    Allen PJ, Busam K, Hill AD, Stojadinovic A, Coit DG. Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer 2001;92:1650–5PubMedCrossRefGoogle Scholar
  48. 48.
    Duker I, Starz H, Bachter D, Balda BR. Prognostic and therapeutic implications of sentinel lymphonodectomy and S-staging in Merkel cell carcinoma. Dermatology 2001;202:225–9PubMedCrossRefGoogle Scholar
  49. 49.
    Rodrigues LK, Leong SP, Kashani-Sabet M, Wong JH. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol 2001;45:303–8PubMedCrossRefGoogle Scholar
  50. 50.
    Pan D, Narayan D, Ariyan S. Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases. Plast Reconstr Surg 2002;110:1259–65PubMedCrossRefGoogle Scholar
  51. 51.
    Morrison WH, Peters LJ, Silva EG, Wendt CD, Ang KK, Goepfert H. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990;19:583–91PubMedGoogle Scholar
  52. 52.
    Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999;229:97–105PubMedCrossRefGoogle Scholar
  53. 53.
    Veness MJ, Morgan GJ, Gebski V. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck 2005;27:208–16PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Sofiane Maza
    • 1
  • Uwe Trefzer
    • 2
  • Maja Hofmann
    • 2
  • Silke Schneider
    • 2
  • Christiane Voit
    • 2
  • Thomas Krössin
    • 1
  • Andreas Zander
    • 1
  • Heike Audring
    • 3
  • Wolfram Sterry
    • 2
  • Dieter L. Munz
    • 1
  1. 1.Clinic for Nuclear MedicineCharité – Universitätsmedizin BerlinBerlinGermany
  2. 2.Department of Dermatology and Allergy, Skin Cancer CentreCharité – Universitätsmedizin BerlinBerlinGermany
  3. 3.Division of DermatopathologyCharité – Universitätsmedizin BerlinBerlinGermany

Personalised recommendations